Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.75 |
| ▸ | PAM | P19021 | 2/20 | 0.67 |
| ▸ | TSHR | P16473 | 2/20 | 0.62 |
| ▸ | MAPT | P10636 | 1/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 4/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | PRKCA | P17252 | 1/20 | 0.55 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.55 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.55 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hexane SCHEMBL3151787 | 1.00 | DGKA (0.75) | DGKAPAMTSHRMAPTCYP1A2 | |
| SCHEMBL900615 | 1.00 | DGKA (0.75) | DGKAPAMTSHRMAPTCYP1A2 | |
| Hexane SCHEMBL2349171 | 1.00 | DGKA (0.75) | DGKAPAMTSHRMAPTCYP1A2 | |
| Hexane SCHEMBL3138126 | 1.00 | DGKA (0.75) | DGKAPAMTSHRMAPTCYP1A2 | |
| SCHEMBL6443707 | 1.00 | DGKA (0.75) | DGKAPAMTSHRMAPTCYP1A2 | |
| SCHEMBL8322451 | 1.00 | DGKA (0.75) | DGKAPAMTSHRMAPTCYP1A2 | |
| SCHEMBL116995 | 1.00 | DGKA (0.75) | DGKAPAMTSHRMAPTCYP1A2 | |
| SCHEMBL454 | 1.00 | DGKA (0.75) | DGKAPAMTSHRMAPTCYP1A2 | |
| Hexane SCHEMBL5994259 | 1.00 | DGKA (0.75) | DGKAPAMTSHRMAPTCYP1A2 | |
| SCHEMBL8375548 | 1.00 | DGKA (0.75) | DGKAPAMTSHRMAPTCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 265 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260028562-A1 | FLAVORED POROUS MATERIAL FOR FLAVORED BEVERAGE PRODUCTION | DANSTAR FERMENT AG (CH) | 2026-01-29 | — | — | US | claimed |
| US-12428360-B2 | Abating unwanted emulsion polymerization during extractive distillation of conjugated diene monomers | ECOLAB USA INC. (US) | 2025-09-30 | — | — | US | claimed |
| EP-4557970-A1 | FLAVORED POROUS MATERIAL FOR FLAVORED BEVERAGE PRODUCTION | Danstar Ferment AG (CH) | 2025-05-28 | — | — | EP | claimed |
| CN-119667039-A | White spirit identification method based on component dimension | 贵州习酒投资控股集团有限责任公司 | 2025-03-21 | — | — | CN | claimed |
| EP-4504680-A1 | ABATING UNWANTED EMULSION POLYMERIZATION DURING EXTRACTIVE DISTILLATION OF CONJUGATED DIENE MONOMERS | ECOLAB USA INC. (US) | 2025-02-12 | — | — | EP | claimed |
| CN-119013243-A | Reduction of unwanted emulsion polymerization during extractive distillation of conjugated diene monomers | 埃科莱布美国股份有限公司 | 2024-11-22 | — | — | CN | claimed |
| CN-118792220-A | Lactobacillus curvatus and application thereof in food | 西南大学 | 2024-10-18 | — | — | CN | claimed |
| US-20240269292-A1 | INTRAVITREAL MITOCHONDRIAL-TARGETED PEPTIDE PRODRUGS AND METHODS OF USE | EYEDEA BIO, LLC | 2024-08-15 | — | — | US | claimed |
| US-20240269320-A1 | EXTENDED RELEASE DRUG DELIVERY SYSTEM FOR OCULAR DRUGS AND METHODS OF USE | EYEDEA BIO, LLC | 2024-08-15 | — | — | US | claimed |
| CN-117925426-A | Rhodotorula mucilaginosa (Rhodotorula mucilaginosa) strain 147 and application, product and method thereof | 宁夏农产品质量标准与检测技术研究所(宁夏农产品质量监测中心) | 2024-04-26 | — | — | CN | claimed |
| CN-103338743-B | A kind of Cleasing compositions of stiff | SUZHOU YUANSUJI CHEMICAL INDUSTRY Co.,Ltd. (CN) | 2016-06-01 | — | — | CN | claimed |
| CN-103338743-A | Thick cleaning composition | SUZHOU YUANSUJI CHEMICAL INDUSTRY CO LTD | 2013-10-02 | — | — | CN | claimed |
| CN-1287694-C | Ambient stable beverage | UNILEVER PLC (NL) | 2006-12-06 | — | — | CN | claimed |
| CN-1192766-C | Method for developing, testing and using associates of macromolecules and complex aggregates for improved payload and controllable De/association rates | IDED INNOVATIVE DERMALE APPLIK (DE) | 2005-03-16 | — | — | CN | claimed |
| CN-1441641-A | Ambient stable beverage | UNILEVER PLC (NL) | 2003-09-10 | — | — | CN | claimed |
| CN-1359288-A | Improved method of transport across an adaptable semi-permeable barrier | IDEA AG (DE) | 2002-07-17 | — | — | CN | claimed |
| JP-2001520304-A | — | — | 2001-10-30 | — | — | JP | claimed |
| CN-1283107-A | Methods of developing, testing and using complexes of macromolecules and complex aggregates for improved payload and controllable dissociation/association rates | IDED INNOVATIVE DERMALE APPLIK (DE) | 2001-02-07 | — | — | CN | claimed |
| EP-1025190-A2 | FATTY ACIDS, SOAPS, SURFACTANT SYSTEMS, AND CONSUMER PRODUCTS BASED THEREON | THE PROCTER & GAMBLE COMPANY (US) | 2000-08-09 | — | — | EP | claimed |
| WO-1999020722-A2 | FATTY ACIDS, SOAPS, SURFACTANT SYSTEMS, AND CONSUMER PRODUCTS BASED THEREON | THE PROCTER & GAMBLE COMPANY (US) | 1999-04-29 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240269292-A1 | INTRAVITREAL MITOCHONDRIAL-TARGETED PEPTIDE PRODRUGS AND METHODS OF USE | PDF, PITRM1, ATP5PD | DGKA 4152/4885PAM 879/4885TSHR 2224/4885 |
| US-12428360-B2 | Abating unwanted emulsion polymerization during extractive distillation of conjugated diene monomers | DDT, PLD1, PNMT | DGKA 11/4885PAM 1222/4885TSHR 4771/4885 |
| US-20240269320-A1 | EXTENDED RELEASE DRUG DELIVERY SYSTEM FOR OCULAR DRUGS AND METHODS OF USE | CHMP4B, UACA, VEGFA | DGKA 4355/4885PAM 4745/4885TSHR 822/4885 |
| US-20260028562-A1 | FLAVORED POROUS MATERIAL FOR FLAVORED BEVERAGE PRODUCTION | CD69, SORD, TAS2R13 | DGKA 819/4885PAM 3339/4885TSHR 4692/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.